[HTML][HTML] An inflammatory cytokine signature predicts COVID-19 severity and survival
…, AW Charney, A Firpo-Betancourt, DR Mendu… - Nature medicine, 2020 - nature.com
Several studies have revealed that the hyper-inflammatory response induced by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease severity …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease severity …
[HTML][HTML] Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a new human disease with few effective treatments 1 . …
coronavirus 2 (SARS-CoV-2), is a new human disease with few effective treatments 1 . …
Neutralizing antibody responses in COVID-19 convalescent sera
…, S Arinsburg, FT Nguyen, DR Mendu… - The Journal of …, 2021 - academic.oup.com
Passive transfer of antibodies from COVID-19 convalescent patients is being used as an
experimental treatment for eligible patients with SARS-CoV-2 infections. The United States …
experimental treatment for eligible patients with SARS-CoV-2 infections. The United States …
Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electrospray tandem mass spectrometry
T Guo, LM Oswald, DR Mendu, SJ Soldin - Clinica chimica acta, 2007 - Elsevier
BACKGROUND: Levetiracetam (Keppra) is a novel antiepileptic drug recently approved by
the US Food and Drug Administration as an add-on therapy in the treatment of partial onset …
the US Food and Drug Administration as an add-on therapy in the treatment of partial onset …
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
…, M Mansour, M McMahon, P Meade, DR Mendu… - Science, 2020 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global
pandemic with millions infected and more than 1 million fatalities. Questions regarding the …
pandemic with millions infected and more than 1 million fatalities. Questions regarding the …
Affinity chromatography of α-amylase from Bacillus licheniformis
DR Mendu, BVV Ratnam, A Purnima… - Enzyme and microbial …, 2005 - Elsevier
An affinity chromatographic method with a novel eluant from Bacillus licheniformis is described.
α-amylase was bound to starch, starch-celite, starch-Sepharose columns and the bound …
α-amylase was bound to starch, starch-celite, starch-Sepharose columns and the bound …
SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
…, M Mansour, M McMahon, P Meade, DR Mendu… - MedRxiv, 2020 - medrxiv.org
SARS-CoV-2 has caused a global pandemic with millions infected and numerous fatalities.
Questions regarding the robustness, functionality and longevity of the antibody response to …
Questions regarding the robustness, functionality and longevity of the antibody response to …
Optimization of fermentation conditions for the production of ethanol from sago starch by co-immobilized amyloglucosidase and cells of Zymomonas mobilis using …
VVR Bandaru, SR Somalanka, DR Mendu… - Enzyme and microbial …, 2006 - Elsevier
Statistical experimental design was used to optimize the conditions of simultaneous
saccharification and fermentation (SSF), viz. temperature, pH and time of fermentation of ethanol …
saccharification and fermentation (SSF), viz. temperature, pH and time of fermentation of ethanol …
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
The coronavirus disease 2019 (COVID-19) pandemic has presented a global challenge. The
pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
[HTML][HTML] Prevalence of SARS-CoV-2 antibodies among healthcare workers at a tertiary academic hospital in New York City
…, E Leven, K Muellers, K Stone, DR Mendu… - Journal of general …, 2020 - Springer
METHODS We collected serum IgG antibody titers from self-referred HCW throughout our
health system using a serologic ELISA assay. 3 In week 1, we tested HCW in departments with …
health system using a serologic ELISA assay. 3 In week 1, we tested HCW in departments with …